North America Organ-on-Chip Market Report 2021: Regional Insights on Annual Revenues by Offering, Organ Type, Material, Application, End User, and Country

News provided by

Dec 17, 2021, 08:00 ET

DUBLIN, Dec. 17, 2021 /PRNewswire/ -- The "North America Organ-on-Chip Market 2020-2030" report has been added to ResearchAndMarkets.com's offering.

North America's organ-on-chip market is expected to grow by 33.7% annually in the forecast period and reach $178.6 million by 2030 owing to the rising use of organ-on-a-chip (OOC) in early detection of drug toxicity, increasing demand for personalized medicine, the emergence of OOC as an alternative to animal testing, the significant increase in research funding and venture capital investments.

Highlighted with 23 tables and 47 figures, this 99-page report is based on a comprehensive research of the entire North America organ-on-chip market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain.

The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year because 2020 is not appropriate for research base due to the outbreak of COVID-19.

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter's Five Forces

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America organ-on-chip market in every aspect of the classification from perspectives of Offering, Organ Type, Material, Application, End User, and Country.

Based on Offering (Annual Revenue in $M for 2019-2030)

Chips
Service

Based on Organ Type (Annual Revenue in $M for 2019-2030)

Liver-on-a-Chip
Heart-on-a-Chip
Lung-on-a-Chip
Kidney-on-a-Chip
Brain-on-a-Chip
Skin-on-a-Chip
Vessels-on-a-Chip
Other Organ Types

Based on Material (Annual Revenue in $M for 2019-2030)

Polymers
Glass
Silicon

Based on Application (Annual Revenue in $M for 2019-2030)

Drug Discovery
Toxicology Research
Other Applications

Based on End User (Annual Revenue in $M for 2019-2030)

Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Cosmetics Industry
Other End Users

Geographically, the following national/local markets are fully investigated:

U.S.
Canada
Mexico

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of key national markets by Organ Type, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players

AxoSim Inc.
BiomimX SRL
Cherry Biotech
CN Bio Innovations, Ltd.
Emulate Inc.
Hurel Corporation
InSphero AG
Kirkstall, Ltd.
MIMETAS BV
Nortis Inc.
Organovo, Inc.
SynVivo, Inc.
Tara Biosystems Inc.
TissUse GmbH

For more information about this report visit https://www.researchandmarkets.com/r/4ag37e

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets